Daniel Blackman
Overview
Explore the profile of Daniel Blackman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
365
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Teles R, Van Belle E, Parma R, Tarantini G, van Mieghem N, Mylotte D, et al.
EuroIntervention
. 2024 Aug;
PMID: 39207816
The percutaneous treatment of structural, valvular, and non-valvular heart disease (SHD) is rapidly evolving. The Core Curriculum (CC) proposed by the EAPCI describes the knowledge, skills, and attitudes that define...
2.
Zaman A, Prendergast B, Hildick-Smith D, Blackman D, Anderson R, Spence M, et al.
Interv Cardiol
. 2023 Jul;
18:e13.
PMID: 37398870
Transcatheter aortic valve implantation (TAVI) is an effective and established treatment for symptomatic aortic stenosis. However, there is a lack of consensus concerning the need for peri- and post-procedural anti-thrombotic...
3.
Tarantini G, Tang G, Fovino L, Blackman D, Van Mieghem N, Kim W, et al.
EuroIntervention
. 2023 Feb;
19(1):37-52.
PMID: 36811935
Significant coronary artery disease (CAD) is a frequent finding in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI), and the management of these two conditions becomes of...
4.
Tarantini G, Delgado V, De Backer O, Sathananthan J, Treede H, Saia F, et al.
Am J Cardiol
. 2023 Jan;
192:228-244.
PMID: 36710143
Recent guidelines on valvular heart disease in Europe and the United States have expanded the indications for transcatheter aortic valve implantation (TAVI) to younger patients and those at lower surgical...
5.
Nuis R, Van Belle E, Teles R, Blackman D, Veulemans V, Amat Santos I, et al.
Am Heart J
. 2022 Nov;
256:139-147.
PMID: 36410441
Background: Surgical aortic valve bioprostheses may degenerate over time and require redo intervention. Transcatheter aortic valve replacement (TAVR) is a less invasive alternative to redo surgery. The BAlloon Expandable vs....
6.
Parfrey S, Abdelrahman A, Blackman D, Blaxill J, Cunnington M, Greenwood J, et al.
BMC Cardiovasc Disord
. 2022 Oct;
22(1):450.
PMID: 36307769
Very short duration of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) has recently attracted a lot of attention with the introduction of newer generations stents. This is appealing,...
7.
Blackman D, Gabbieri D, Garcia Del Blanco B, Kempfert J, Laine M, Mascherbauer J, et al.
Cardiol Ther
. 2021 Jun;
10(2):277-288.
PMID: 34081277
Severe aortic stenosis patients with bicuspid anatomy have been excluded from the major transcatheter aortic valve replacement (TAVI) randomized clinical trials. As a result, there is no official recommendation on...
8.
MacCarthy P, Smith D, Muir D, Blackman D, Buch M, Ludman P, et al.
Interv Cardiol
. 2021 Apr;
16:e03.
PMID: 33897829
No abstract available.
9.
Meduri C, Reardon M, Lim D, Howard E, Dunnington G, Lee D, et al.
JACC Cardiovasc Interv
. 2019 Oct;
12(23):2402-2412.
PMID: 31629753
Objectives: This study proposes a physiologic assessment of left ventricular outflow tract obstruction (LVOTO) that accommodates changes in systolic flow and accounts for the dynamic neo-left ventricular outflow tract (LVOT)....
10.
Bulluck H, Frohlich G, Nicholas J, Mohdnazri S, Gamma R, Davies J, et al.
Am Heart J
. 2019 Mar;
211:60-67.
PMID: 30893577
Background: Mineralocorticoid receptor antagonist (MRA) therapy has been shown to prevent adverse left ventricular (LV) remodeling in ST-segment elevation myocardial infarction (STEMI) patients with heart failure. Whether initiating MRA therapy...